EndoClot PHS
Commercial- Indications
- Gastrointestinal bleeding
Company intelligence / Profile preview
EndoClot Plus
Santa Clara, California, United Statesendoclot.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Commercial
01
Overview
EndoClot Plus has developed and commercialized a proprietary polysaccharide-based hemostatic powder system and a starch-derived submucosal injection agent. These products have demonstrated excellent safety profiles and are used widely in GI endoscopy to control bleeding and facilitate lesion removal. The company’s technologies are FDA-cleared for use in the U.S. market as of 2020, with distribution partnerships expanding their reach across the U.S. and internationally.
- Therapeutic areas
- Gastroenterology
- Modalities
- DeviceBiologic (biomaterial-based medical devices)
- Industry
- Surgical Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Olympus Corporation – exclusive U.S. distributor since 2022; also distribution agreement in EMEA region
Beyond the preview
Go deeper on EndoClot Plus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EndoClot Plus.